Volume 120, Issue 4, March 2024

First-in-human gene editing for lipid lowering: the initial results

• Extract
• View article

Understanding and controlling the increasing burden of cardiovascular diseases in Africa

• Extract
• View article

A new year’s resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodelling

• Extract
• View article

Abdominal aortic aneurysms and platelets: infiltration, inflammation, and elastin disintegration

• Extract
• View article

Effect of lipid-lowering therapies on C-reactive protein levels: a comprehensive meta-analysis of randomized controlled trials

• Abstracts
• View article
• Supplementary data

An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction

• Abstracts
• View article
• Supplementary data

Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction

• Abstracts
• View article
• Supplementary data

Networks of gut bacteria relate to cardiovascular disease in a multi-ethnic population: the HELIUS study

• Abstracts
• View article
• Supplementary data

Cyclophilin A is a ligand for RAGE in thrombo-inflammation

• Abstracts
• View article
• Supplementary data

Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation

• Abstracts
• View article
• Supplementary data

Crosstalk of platelets with macrophages and fibroblasts aggravates inflammation, aortic wall stiffening, and osteopontin release in abdominal aortic aneurysm

• Abstracts
• View article
• Supplementary data

Expression of Concern: Transcription factor Krüppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation

• Extract
• View article

Correction to: Contractility measurements for cardiotoxicity screening with ventricular myocardial slices of pigs

• Extract
• View article